¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023³â Á¦20Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ ÀÎõ°æ±âÁöȸ Çмú´ëȸ : 2023-12-02

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023³â Á¦20Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ ÀÎõ°æ±âÁöȸ Çмú´ëȸ : 2023-12-02
±³À°ÀÏÀÚ : 2023-12-02
±³À°Àå¼Ò : ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÁöÇÏ1Ãþ ´ë°­´ç

±³À°ÁÖÁ¦ : 2023³â Á¦20Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ ÀÎõ°æ±âÁöȸ Çмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇѺñ´¢ÀÇÇÐȸ(19.2 ¸íĪº¯°æ ´ëÇѺñ´¢±â°úÇÐȸ)
½ÃÇà±â°ü(ÁöºÎ/°ú) : ÀÎõ°æ±âÁöȸ

´ã´çÀÚ : À̼¼Èñ
¿¬¶ôó : 02-573-8190

À̸ÞÀÏ : urology@urology.or.kr

±³À°Á¾·ù : ºñ´¢ÀÇÇаú

Âü¼®¿¹»óÀÎ : 50¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : °æ±âµµ
±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 12¿ù 02ÀÏ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°­´ç 12:30~13:00 µî·Ï ( )

±âŸ 12¿ù 02ÀÏ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°­´ç 13:00~13:10 Àλ縻 ¾ÈÇö¼ö(¾ÆÁÖÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°­´ç 13:10~13:25 Impact of incontinence surgery in female sexual function À̼ҿ¬(ÇѾçÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°­´ç 13:25~13:40 Update on medical treatment of BPH À¯¿µµ¿(ºÐ´çÂ÷º´¿ø)

±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°­´ç 13:40~13:55 Current state of AI toward automated surgery ±èÁø¿í(Áß¾ÓÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°­´ç 13:55~14:10 Update on surgical treatment of BPH ¹è»ó¶ô(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°­´ç 14:10~14:25 Individualizing care of low-risk prostate cancer in the era of active surveillance Źü½Ä(°í·ÁÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°­´ç 14:25~14:40 Lymph node dissection at radical prostatectomy ¹ÚºÀÈñ(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°­´ç 14:40~14:55 How systemic treatment should be used for men with high-risk localized prostate cancer? ³ªÁØä(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°­´ç 14:55~15:10 PARP inhibitors for mCRPC: for all or for biomarker-dependent? ÃÖÁß¿ø(Áß¾ÓÀÇ´ë)

ÈÞ½Ä 12¿ù 02ÀÏ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°­´ç 15:10~15:30 ´Üü»çÁø ¹× Coffee break ( )

±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°­´ç 15:30~15:45 Second line therapy for NMIBC recurrence after BCG therapy ±ÇÈÖ¾È(ÇѾçÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°­´ç 15:45~16:00 Radical cystectomy in the elderly and co- morbidity Ãß¼³È£(¾ÆÁÖÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°­´ç 16:00~16:15 Tips and tricks for complex renal tumor surgery ±èÁ¤±Ç(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°­´ç 16:15~16:30 Who is the best candidate for adjuvant therapy in RCC? ±èÇüÈ£(±¹¸³¾Ï¼¾ÅÍ)

±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°­´ç 16:30~16:45 What¡¯s New in Disposable Flexible Ureteroscope? ±è¿õºó(¼øõÇâÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°­´ç 16:45~17:00 Medical Expulsive Therapy for Urolithiasis Á¤µÎ¿ë(ÀÎÇÏÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°­´ç 17:00~17:15 Guidelines of UTI Diagnosis in Korea ÃÖÁøºÀ(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 12¿ù 02ÀÏ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°­´ç 17:15~17:30 STI Prevalence, Incidence, and Trends in Korea ÃÖâÀÏ(ÇѸ²ÀÇ´ë)

±âŸ 12¿ù 02ÀÏ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°­´ç 17:30~18:00 ÀÎõ-°æ±âÁöȸ ÃÑȸ Á¤¼ºÁø(¼­¿ïÀÇ´ë)

±âŸ 12¿ù 02ÀÏ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÁöÇÏ 1 Ãþ ´ë°­´ç 18:00~18:10 Closing ( )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023³â Á¦20Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ ÀÎõ°æ±âÁöȸ Çмú´ëȸ : 2023-12-02""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑ¿µ»óÀÇÇÐȸ ºÎ¿ï°æÁöȸ Àü¹®ÀÇ¿¬¼ö±³À° : 2023-12-02
´ÙÀ½±Û 2023³â Á¦12ȸ ´ëÇѺñ´¢»ý½Ä±âÅëÇÕ±â´ÉÀÇÇבּ¸È¸ Çмú´ëȸ : 2023-12-02
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 39 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 45 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 47 2024-05-28
20910 ¼­¿ï 2024³â Á¦14ȸ °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ³»ºÐºñ³»°ú ¿¬¼ö°­Á : 2024-07-07 0 24 2024-05-28
20909 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø Á¤Çü¿Ü°ú 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-07-07 0 27 2024-05-28
20908 ¼­¿ï Á¦19Â÷ ´ëÇѸðÀ¯¼öÀ¯ÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-07-07 0 18 2024-05-28
20907 °æ±â Á¦2Â÷ ´ëÇѽŰæ¹æ»ç¼±¼ö¼úÇÐȸ Á¤±âÇмú´ëȸ : 2024-07-06 0 15 2024-05-28
20906 °æ±â Á¦ 5ȸ ¿À»ê½ÃÀÇ»çȸ Çмú´ëȸ : 2024-07-06 0 18 2024-05-28
20905 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦3ȸ ¾Æ»êµÎ°æºÎ Æ÷·³ : 2024-07-06 0 21 2024-05-28
20904 ¼­¿ï 2024³â Á¦2ȸ °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø ¼øȯ±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-06 0 22 2024-05-28
20903 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day3) : 2024-07-06 0 20 2024-05-28
20902 ¼­¿ï ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ 2024³â ÇÏ°è NeurocrItical Care Essence (NICE) ¾ÆÄ«µ¥¹Ì : 2024-07-06 0 12 2024-05-28
20901 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦10ȸ ºÎ½Å¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06 0 16 2024-05-28
20900 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day2) : 2024-07-05 0 7 2024-05-28
20899 ¼­¿ï ÀÓ»ó¼ú±â±³À°¿¬±¸È¸ Á¦16ȸ ÀÓ»ó¼ú±â ¿¬¼ö°­Á : 2024-07-04 0 18 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷